Showing results (2101-2110 of 2,409) with videos related to

Sort By:
Pageof 241
Cell Reports|April 22, 2014
Uterine leiomyoma-linked MED12 mutations disrupt mediator-associated CDK activityMikko Turunen, Jason M Spaeth, Salla Keskitalo, et al.
International Journal of Epidemiology|February 9, 2026
Impact of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine on sexually transmitted and reproductive tract infections: results from a randomized trial in UgandaHarriet Adrama, Erin J Dela Cruz, Nida Ozarslan, et al.
American Journal of Hypertension|June 6, 2013
Blood pressure after recent stroke: baseline findings from the secondary prevention of small subcortical strokes trialCarole L White, Pablo E Pergola, Jeff M Szychowski, et al.
American Journal of Human Genetics|January 13, 2000
Full-genome scan for linkage in 50 families segregating the bipolar affective disease phenotypeC Friddle, R Koskela, K Ranade, et al.
Cell|January 30, 2016
Parsing the Interferon Transcriptional Network and Its Disease AssociationsSara Mostafavi, Hideyuki Yoshida, Devapregasan Moodley, et al.
The Lancet. HIV|March 5, 2016
A hybrid mobile approach for population-wide HIV testing in rural east Africa: an observational studyGabriel Chamie, Tamara D Clark, Jane Kabami, et al.
Antimicrobial Agents and Chemotherapy|October 6, 2020
Piperaquine Exposure Is Altered by Pregnancy, HIV, and Nutritional Status in Ugandan WomenEmma Hughes, Marjorie Imperial, Erika Wallender, et al.
Annals of the American Thoracic Society|May 1, 2023
Research Bronchoscopies in Critically Ill Research Participants: An Official American Thoracic Society Workshop ReportCarmen Mikacenic, Lynn A Fussner, Jasmine Bell, et al.
BMJ Open|July 9, 2025
Developing a core outcome set for gender-affirming healthcare in transgender and gender diverse adults in Sweden using the Delphi approach: a study protocolLisann Dahlén, Klara Pettersson, Frank Berglund, et al.
Molecular Cancer Therapeutics|August 28, 2020
Pharmacologic Properties and Preclinical Activity of Sasanlimab, A High-affinity Engineered Anti-Human PD-1 AntibodyAmir A Al-Khami, Sawsan Youssef, Yasmina Abdiche, et al.
Pageof 241